Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Opiant Pharmaceuticals Inc (OTCQB:OPNT)

7.42
Delayed Data
As of Aug 26
 -0.05 / -0.67%
Today’s Change
6.00
Today|||52-Week Range
14.00
-24.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues870.0K120.0K6.9M2.6M
 
 
 
 
 
Depreciation And Amortization343.00343.00343.00501.00
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses2.4M11.2M2.9M2.2M
 
 
 
 
 
Research And Development1.1M429.5K373.1K1.1M
 
 
 
 
 
Total Operating Expenses2.4M11.2M2.9M2.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.5M-11.1M4.0M411.9K
 
 
 
 
 
Interest Expense On Debt4.8K5.8K5.5K0.00
 
 
 
 
Other Expenses-102.9K-3.4K-25.8K4.3K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.6M-11.1M4.0M416.1K
 
 
 
 
 
Net Income-1.6M-11.1M4.0M416.1K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS4.0M1.9M1.9M1.9M
 
 
 
 
 
Shares To Calculate EPS Diluted4.0M1.9M2.6M2.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.89-$6.00$1.52$0.15
 
 
 
 
 
EPS Diluted-$0.41-$6.00$1.52$0.15